<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of SB1971</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					SB1971 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>SB1971</pre></b></center><p> </p>Introduced 2/6/2025, by Sen. Rachel Ventura<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>New Act</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Creates the Wholesale Prescription Drug Importation Program Act. </code><code>Requires the Department of Public Health to establish the Wholesale </code><code>Prescription Drug Importation Program. Provides that the Department shall </code><code>implement the program by: (1) contracting with one or more prescription </code><code>drug wholesalers and Canadian suppliers to import prescription drugs and </code><code>provide prescription drug cost savings to consumers in this State; (2) </code><code>developing a registration process for health benefit plan issuers, health </code><code>care providers, and pharmacies to obtain and dispense prescription drugs </code><code>imported under the program; (3) developing a list of prescription drugs, </code><code>including the prices of those drugs, that meet certain requirements set </code><code>forth under the Act and publishing the list on the Department's website; </code><code>(4) establishing an outreach and marketing plan to generate program </code><code>awareness; (5) ensuring the program and the prescription drug wholesalers </code><code>that contract with this State comply with certain federal tracking, </code><code>tracing, verification, and identification requirements; and other matters. </code><code>Sets forth eligibility criteria for prescription drugs that may be </code><code>imported into the State under the program. Contains provisions concerning </code><code>program expansion; program funding; audit procedures; annual reporting </code><code>requirements; the adoption of rules to implement the Act; and federal </code><code>waiver or authorization requirements. Effective July 1, 2025.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1971</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning health.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 1. </code><code>Short title. </code><code>This Act may be cited as the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Wholesale Prescription Drug Importation Program Act.</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>Definitions. </code><code>As used in this Act: </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Canadian supplier" means a manufacturer, wholesale </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>distributor, or pharmacy that is appropriately licensed or </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>permitted under Canadian federal or provincial laws and rules </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>to manufacture, distribute, or dispense prescription drugs. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Department" means the Department of Public Health. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Director" means the Director of Public Health.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Prescription drug wholesaler" means a person or entity </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>licensed as a wholesale drug distributor under the Wholesale </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>Drug Distribution Licensing Act, that contracts with this </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>State to import prescription drugs under the program. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Program" means the Wholesale Prescription Drug </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Importation Program.</code><br> </td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>Wholesale Prescription Drug Importation </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>Program. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) The Department shall establish the Wholesale </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>Prescription Drug Importation Program to provide lower cost </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1971</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>prescription drugs available outside of the United States to </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>consumers in this State at the lower cost. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) The Department shall implement the program by:</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) contracting with one or more prescription drug </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>wholesalers and Canadian suppliers to import prescription </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>drugs and provide prescription drug cost savings to </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>consumers in this State;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) developing a registration process for health </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>benefit plan issuers, health care providers, and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>pharmacies to obtain and dispense prescription drugs </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>imported under the program;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) developing a list of prescription drugs, including </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>the prices of those drugs, that meet the requirements of </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>Section 15 and publishing the list on the Department's </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>website; </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) establishing an outreach and marketing plan to </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>generate program awareness;</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) establishing and administering a telephone call </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>center or electronic portal to provide information about </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>the program;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) ensuring the program and the prescription drug </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>wholesalers that contract with this State under paragraph </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>(1) comply with the tracking, tracing, verification, and </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>identification requirements of 21 U.S.C. 360eee-1;</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) prohibiting the distribution, dispensing, or sale </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>of prescription drugs imported under this Act outside the </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1971</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>boundaries of this State; and </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) performing any other duties the Director </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>determines necessary to implement the program. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) The Department shall ensure that the program meets the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>requirements of 21 U.S.C. 384.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) In developing the program, the Department may consult </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>with interested parties. </code><br> </td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 15. </code><code>Eligible prescription drugs. </code><code>A prescription </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>drug may be imported into this State under the program only if </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>the drug:</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) meets the United States Food and Drug </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>Administration's standards related to prescription drug </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>safety, effectiveness, misbranding, and adulteration;</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) does not violate any federal patent laws through </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>its importation; </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) is expected to generate cost savings for </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>consumers; and</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) is not:</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) listed as a controlled substance under State </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>or federal law;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) a biological product;</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) an infused drug;</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) an intravenously injected drug;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(E) a drug that is inhaled during surgery; or</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(F) a parenteral drug. </code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1971</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 20. </code><code>Program expansion. </code><code>In its discretion, the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>Department may, by rule, expand the Program to import </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>prescription drugs from any other country that is allowed </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>under federal law to import prescription drugs into the United </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>States. </code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 25. </code><code>Program funding. </code><code>In addition to money </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>appropriated by the General Assembly, the Department may </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>impose a fee on each prescription drug sold under the program </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>or establish another funding method to administer the program. </code><br> </td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 30. </code><code>Audit procedures. </code><code>The Director, by rule, shall </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>develop procedures to effectively audit a prescription drug </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>wholesaler participating in the program. </code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 35. </code><code>Annual reporting. </code><code>Not later than December 1, </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>2025, and each December 1 thereafter, the Department shall </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>submit a report to the Governor and the General Assembly </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>regarding the operation of the program during the preceding </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>State fiscal year, including: </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) which prescription drugs and Canadian suppliers </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>are included in the program;</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the number of health benefit plan issuers, health </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>care providers, and pharmacies participating in the </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>program; </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">SB1971</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 08325 BAB 18376 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the number of prescriptions dispensed through the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>program; </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) the estimated cost savings to consumers, health </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>plans, employers, and this State since the establishment </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>of the program and during the preceding State fiscal year; </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) information regarding the implementation of the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>audit procedures under Section 30; and </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) any other information: </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) the Governor or the General Assembly requests; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >        <code>or</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) the Department considers necessary. </code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 40. </code><code>Rules. </code><code>As soon as practicable after the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>effective date of this Act, the Director shall adopt any rules </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>necessary to implement this Act. </code><br> </td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 45. </code><code>Federal waiver or authorization. </code><code>If, before </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>implementing any provision of this Act, a State agency </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>determines that a waiver or authorization from a federal </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>agency is necessary for implementation of that provision, the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>agency affected by the provision shall request the waiver or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>authorization and may delay implementing that provision until </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>the waiver or authorization is granted. </code><br> </td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 99. </code><code>Effective date. </code><code>This Act takes effect July 1, </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>2025.</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
